WO2001038534A3 - Human serpin - Google Patents

Human serpin Download PDF

Info

Publication number
WO2001038534A3
WO2001038534A3 PCT/US2000/032100 US0032100W WO0138534A3 WO 2001038534 A3 WO2001038534 A3 WO 2001038534A3 US 0032100 W US0032100 W US 0032100W WO 0138534 A3 WO0138534 A3 WO 0138534A3
Authority
WO
WIPO (PCT)
Prior art keywords
serine protease
serpin
serine
family
disorders
Prior art date
Application number
PCT/US2000/032100
Other languages
French (fr)
Other versions
WO2001038534A2 (en
Inventor
James L Holloway
Original Assignee
Zymogenetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics Inc filed Critical Zymogenetics Inc
Priority to AU22504/01A priority Critical patent/AU2250401A/en
Publication of WO2001038534A2 publication Critical patent/WO2001038534A2/en
Publication of WO2001038534A3 publication Critical patent/WO2001038534A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81Protease inhibitors
    • C07K14/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121Serpins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Members of the serine protease family play a role in carefully controlled processes, such as blood coagulation, fibrinolysis, complement activation, fertilization, and hormone production. The enzymatic activity of the serine proteases is regulated in part by serpins, serine protease inhibitors. Serpin dysfunction is associated with various disorders, including emphysema, blood clotting disorders, cirrhosis, Alzheimer disease, and Parkinson disease. Zserp 11 is a new member of the serine protease inhibitor family.
PCT/US2000/032100 1999-11-29 2000-11-20 Human serpin WO2001038534A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU22504/01A AU2250401A (en) 1999-11-29 2000-11-20 Human serpin

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45024499A 1999-11-29 1999-11-29
US09/450,244 1999-11-29

Publications (2)

Publication Number Publication Date
WO2001038534A2 WO2001038534A2 (en) 2001-05-31
WO2001038534A3 true WO2001038534A3 (en) 2002-01-03

Family

ID=23787321

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/032100 WO2001038534A2 (en) 1999-11-29 2000-11-20 Human serpin

Country Status (2)

Country Link
AU (1) AU2250401A (en)
WO (1) WO2001038534A2 (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996034957A1 (en) * 1995-05-02 1996-11-07 Incyte Pharmaceuticals, Inc. Pancreas-derived serpin
WO1996040922A1 (en) * 1995-06-07 1996-12-19 Incyte Pharmaceuticals, Inc. Novel serpin derived from human hypothalamus

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996034957A1 (en) * 1995-05-02 1996-11-07 Incyte Pharmaceuticals, Inc. Pancreas-derived serpin
WO1996040922A1 (en) * 1995-06-07 1996-12-19 Incyte Pharmaceuticals, Inc. Novel serpin derived from human hypothalamus

Also Published As

Publication number Publication date
AU2250401A (en) 2001-06-04
WO2001038534A2 (en) 2001-05-31

Similar Documents

Publication Publication Date Title
Oliva et al. Leucaena leucocephala serine proteinase inhibitor: primary structure and action on blood coagulation, kinin release and rat paw edema
CA2058935A1 (en) Pharmaceutical compositions and method for treatment using alzheimer's amyloid peptides
Patel et al. Purification and physicochemical characterization of a serine protease with fibrinolytic activity from latex of a medicinal herb Euphorbia hirta
PT94016A (en) PROCESS FOR THE PRODUCTION OF PROTEIN INHIBITORS
WO1995023860A3 (en) KUNITZ DOMAIN INHIBITOR PROTEINS DERIVED FROM ALZHEIMER'S AMYLOID β-PROTEIN PRECURSOR INHIBITOR
NZ606504A (en) Modified proteases that inhibit complement activation
NZ596269A (en) Protease screening methods and proteases identified thereby
SE0201980D0 (en) Novel compounds
Wilson et al. Survey of the proteolytic activities degrading the Kunitz trypsin inhibitor and glycinin in germinating soybeans (Glycine max)
IL222773B (en) Biaryl compounds, pharmaceutical compositions comprising the same, use of such compounds in the manufacture of medicaments and in vitro methods and devices using such compounds
IL160295A0 (en) Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidines structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
WO2000051623A3 (en) Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide-induced clinical conditions
WO1996035788A3 (en) Kunitz type protease inhibitors
WO2001044172A8 (en) Salicylamides as serine protease and factor xa inhibitors
MY116539A (en) New amino acid derivatives
UY26154A1 (en) ARIL AND HETEROARIL REPLACED POLYCYCLIC PYRIDONES USEFUL FOR THE SELECTIVE INHIBITION OF THE COAGULATION WATERFALL
AU2003243097A1 (en) Novel compounds
BR0011295A (en) Aryl and heteroaryl substituted polycyclic pyrazinones useful for selective inhibition of coagulation cascade
WO1993009233A3 (en) Recombinant amyloid precursor protein inhibitor domain and treatment of various disease states
WO2002014264A3 (en) (hydroxyethyl)ureas as inhibitors of alzheimer's beta-amyloid production
WO2002014359A3 (en) Human serpin zserp15
NZ319474A (en) Guanidino protease inhibitors
WO2003099202A3 (en) Beta-secretase inhibitors
WO2001038534A3 (en) Human serpin
WO2001031033A3 (en) Protease from lucila sericata and its use in treatment of wounds

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase